Has Kayla Fenske received payments from drug or device companies?

Yes. Drug and device makers reported $2,760 in general payments to Kayla Fenske across 128 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kayla Fenske did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kayla Fenske come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kayla Fenske

Family · Sarasota, FLNPI 1003698861

Payments from drug & device makers

$2,760in general payments, 2019–2025

Across 128 payments — averaging $21.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$210
Daiichi Sankyo Inc.$194
Pfizer$179
Incyte Corporation$152
AbbVie$148
Johnson & Johnson$118
plus $2K from 40 others

What the payments were for

Food & beverage$2,760100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	10	$210
Daiichi Sankyo Inc.	7	$194
Pfizer	11	$179
Incyte Corporation	7	$152
AbbVie	6	$148
Johnson & Johnson	6	$118
Geron Corporation	5	$116
Novartis	5	$115
Otsuka America Pharmaceutical, Inc.	4	$94
Takeda Pharmaceuticals U.S.A., Inc.	3	$92
AstraZeneca(2 entities)	5	$89
E.r. Squibb & Sons, L.L.C.	4	$85
Bristol Myers Squibb	3	$69
Beone Medicines USA, Inc.	3	$69
Lilly USA, LLC	3	$64
Syndax Pharmaceuticals, Inc.	3	$61
Sobi, Inc	2	$61
Puma Biotechnology, Inc.	3	$56
Stemline Therapeutics Inc.	2	$52
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$51
Bayer	3	$47
Dendreon Pharmaceuticals LLC	2	$45
Boehringer Ingelheim	2	$45
Eisai Inc.	2	$44
Sumitomo Pharma America, Inc.	2	$34
Jazz Pharmaceuticals Inc.	1	$32
Exact Sciences	1	$32
Pharmacosmos Therapeutics Inc.	2	$32
Taiho Oncology, Inc.	2	$31
ADC Therapeutics America, Inc.	1	$31
Tempus AI, Inc	1	$27
Hologic Sales And Service, LLC	1	$25
EMD Serono, Inc.	1	$24
Apellis Pharmaceuticals, Inc.	1	$23
Ipsen Biopharmaceuticals, Inc	1	$23
Neuronetics, Inc.	1	$21
Array Biopharma Inc	1	$21
Idorsia Pharmaceuticals US Inc	1	$19
Genmab U.S., Inc.	1	$18
GSK	1	$17
Nevro Corp.	1	$17
Astellas Pharma US Inc	1	$17
Menarini Silicon Biosystems, Inc.	1	$17
Genentech USA, Inc.	1	$16
Noven Therapeutics, LLC	1	$14
Novocure Inc.	1	$14

How this compares

$2,760 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OzempicSemaglutide	11	$12,470
Atorvastatin Calcium	31	$247
Venlafaxine Hcl ErVenlafaxine Hcl	14	$239
Potassium Chloride	12	$190
Levothyroxine Sodium	48	$187
Losartan Potassium	35	$170
Gabapentin	21	$166
Metformin Hcl	24	$157
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide	14	$126
Rosuvastatin Calcium	11	$113
Lisinopril	25	$110
Pantoprazole Sodium	14	$69
Amlodipine Besylate	18	$61
Clonazepam	18	$48

Paid to pharmacies, not to this prescriber.

Other family in Sarasota

Marie ZambelliSarasota$65K
John HuffakerVenice$8M
Stephanie MompointMiami$4.5M
Miguel TrujilloMiami Gardens$4.4M
Itsel Cardenas RamonMiami$1M
Lewis HarringtonTampa$954K
Adam StrosbergFort Lauderdale$859K
Danielle PharesFt Lauderdale$713K
David RodriguezHialeah$658K
Donna OrtizOrlando$417K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →